Customized cancer treatment is the future of cancer therapy, but analyzing the unique genetic make-up of individuals can take an enormous amount of time. It typically takes weeks for clinicians to analyze each genetic mutation, but IBM Watson Genomic Analytics in some cases can complete the process in just a few minutes and produce a report, including treatment recommendations. The ambitious goal is personalized medicine for cancer patients everywhere based on their unique genomic profile.
Last week, IBM Watson Health announced a partnership with 14 organizations to apply their data-crunching abilities with an expanded set of patients by the end of the year. Sanford Health is one of the fourteen. Dr. Steven Powell, oncologist and cancer researcher at Sanford Health in Sioux Falls, joined Dakota Midday and discussed the partnership with IBM Watson Health.